The Cantech Investment Conference 2017 wrapped up last week and “The Emerging Cannabis Sector” panel moderated by Mackie Research Equity Analyst Neal Gilmer, was one to watch.
Not only because it was held during a technology conference, but also because, as Gilmer explained, the cannabis sector is an opportunity investors should look into since it is growing at a very rapid pace.
Members of the panel were a mix of cannabis industry participants that included Michael Gorenstein, President, CEO & Chairman of the Cronos Group (TSXV:MJN), Marc Lustig, CEO of CannaRoyalty (CSE:CRZ), Brad Rogers, CEO of CannTrust, and Robert Lando, CEO of Agronomix.

Opportunities in cannabis

Gilmer started off by asking, “Where do the opportunities lie?”
Rogers thought that opportunities are aplenty, and “the revenue potential is huge both nationally and internationally.” Gorenstein agreed, and said, “we’re really walking into a market where there’s nearly $200 billion in revenue.” He went on to say that they believe in the Canadian market because it is the first G7 country to “recreationalize cannabis consumption.”
Lustig, on the other hand, finds opportunity in “watching the evolution of product development.” He went on further to say that there is tremendous opportunity in Canada, “ if you do things right and work within the confines of the legislation.”

According to Lando, “In any market where things mature, the low cost producer wins so this is an opportunity for those who grow: to take the opportunity with good margins to be able to plow them into low-cost capability so that when the time comes, they’ll be a low cost producer and they’ll be able to make money no matter what the value of the crop is.”

The demand and supply in Canada

Gilmer asked Gorenstein and Rogers about how they saw the cannabis market in Canada in terms of supply and demand. Gorenstein said he sees a very big gap between supply and demand, and that they get a lot of inquiries in the wholesale segment.
Meanwhile, Rogers said, “this industry has a lot of growing up to do, from the regulators to the producers.” He added, ”Because the regulations we work under, our product is worldwide the gold standard. The testing that has to go through the regulatory requirements — although there have been some recalls, etc. — the guys who focus on quality and are able to execute at an enterprise scale, we’re going to win.”
There is no denying that the cannabis sector is booming, and not only for end users. US legalization in late 2016 helped foster growth of this industry, and the Canadian federal government legislation anticipated in 2017 will only enrich it further. With a vast number of companies ranging from growers to dispensaries and even pet products, there is no shortage of ways to get into this market that is said to grow to $21.8 billion by 2020.
Don’t forget to follow us @INN_Cannabis for real-time news updates!
Securities Disclosure: I, Pia Rivera, hold no direct investment interest in any company mentioned in this article.

In the cannabis space this week, retailer Fire & Flower Holdings (TSX:FAF,OTCQX:FFLWF) told investors it will be entering the US market through a novel strategic action.

Meanwhile, two longstanding cannabis partners ended their relationship.

Keep reading... Show less

Trulieve to donate $20,000 in scholarship funding and $15,000 to support leadership development

Trulieve Cannabis Corp . (CSE: TRUL) (OTC: TCNNF), a leading and top-performing cannabis company in the United States today announced a new partnership with the Thurgood Marshall College Fund (TMCF), the nation’s largest organization exclusively representing the Black College Community. Trulieve will donate $20,000 to help fund several college scholarships awarded to students who are attending one of the organization’s member-schools as part of Trulieve’s diversity, equity, and inclusion initiatives. The $15,000 in talent funding is earmarked to support TMCF’s internship program, reaching a diverse talent pool of students and alumni from their 47 member-schools to provide immersive experiences at Trulieve.

Keep reading... Show less

The new dispensary expands patient access to Florida’s largest inventory of medical cannabis products

Trulieve Cannabis Corp. (CSE: TRUL) (OTCQX: TCNNF) (“Trulieve” or “the Company”), a leading and top-performing cannabis company based in the United States announced today the opening of a brand-new Florida dispensary, the Company’s 80th nationwide. The new location marks the Company’s first in Tamarac and third in Broward County expanding patient access to Florida’s largest and broadest assortment of high-quality medical cannabis products.

Keep reading... Show less

Revive Therapeutics Ltd. (“Revive” or the “Company”) (CSE: RVV, USA: RVVTF), a specialty life sciences company focused on the research and development of therapeutics for medical needs and rare disorders, is pleased to announce an update on the Company’s U.S. Food & Drug Administration (“FDA”) Phase 3 clinical trial (the “Study”) to evaluate the safety and efficacy of Bucillamine in patients with mild to moderate COVID-19.

With its recent $23 million dollar financing, the Company plans to aggressively expand from 14 clinical sites to up to 50 clinical sites to meet the next enrollment goals for the Study in Q2-2020. The Study is a randomized, double-blinded, placebo-controlled trial and the safety and efficacy data analyzed at each interim analysis timepoint of 210, 400, 600 and 800 completed patients are only made available to the Independent Data and Safety Monitoring Board (“DSMB”) for review and recommendations on continuation, stopping or changes to the conduct of the Study. In the event of any serious safety concerns, the DSMB would be notified to determine any risks and provide its recommendations. To date, in this initial 210 interim point there have been no serious safety concerns that required the DSMB to be notified.

Keep reading... Show less

HempFusion Wellness Inc. (TSX:CBD.U) (OTCQX:CBDHF) (FWB:8OO) (“HempFusion” or the “Company”), a leading health and wellness CBD company utilizing the power of whole-food hemp nutrition, is pleased to announce that its common shares have been approved for DTC full-service eligibility in the United States by the Depository Trust Company (“DTC”) and can now be both traded and serviced through DTC’s electronic book-entry system.

DTC is a subsidiary of the Depository Trust & Clearing Corp. (“DTCC”) that provides clearing and settlement services for the financial markets and settles the majority of securities transactions in the United States. This electronic method of clearing securities speeds up the receipt of stock and cash and thus accelerates the settlement process for investors and brokers, enabling the stock to be traded over a much wider selection of brokerage firms.

Keep reading... Show less